Histidyl–tRNA Synthetase and Asparaginyl–tRNA Synthetase, Autoantigens in Myositis, Activate Chemokine Receptors on T Lymphocytes and Immature Dendritic Cells
O. M. Zack Howard(Center for Cancer Research), Joost J. Oppenheim(Frederick National Laboratory for Cancer Research), Kanneboyina Nagaraju(Children's National), Kwabena Yiadom(Georgetown University), De Yang(Cancer Research Center), Paul H. Plötz(National Institutes of Health), Nina Raben(APT Therapeutics (United States)), David C.H. Yang(University of California Davis Medical Center), Michael Härtlein(Institut Langevin), Hui Dong(Shandong University), Michael Kron(Michigan State University), Livia Casciola‐Rosen(Johns Hopkins University), Sunita Dwivedi(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Antony Rosen(Johns Hopkins University)
Cited by 276
Related Papers
Ll-37, the Neutrophil Granule–And Epithelial Cell–Derived Cathelicidin, Utilizes Formyl Peptide Receptor–Like 1 (Fprl1) as a Receptor to Chemoattract Human Peripheral Blood Neutrophils, Monocytes, and T Cells
|The Journal of Experimental Medicine|2000|1.2k
Therapy of Lupus Nephritis
|New England Journal of Medicine|1986|1.2k
A New Approach to the Classification of Idiopathic Inflammatory Myopathy
|Medicine|1991|974
Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line.
|The Journal of Experimental Medicine|1989|765
Defective Reticuloendothelial System Fc-Receptor Function in Systemic Lupus Erythematosus
|New England Journal of Medicine|1979|531